Related Experiment Video

Updated: Sep 4, 2026

Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

ARTIFICIAL CARDIAC PACEMAKERS

J B BUTTIGLIERO, J C COLES, N F GERGELY

    Canadian Medical Association Journal
    |August 15, 1964
    PubMed

    Insights

    Artificial cardiac pacemakers effectively treated patients with complete heart block and Stokes-Adams disease. Eight of nine patients experienced improved physical activity and freedom from seizures after pacemaker implantation.

    Area of Science:

    • Cardiology
    • Biomedical Engineering

    Background:

    • Complete heart block and Stokes-Adams disease significantly impair patients, often rendering them bedridden.
    • Medical treatments for these conditions can be insufficient, necessitating alternative interventions.

    Purpose of the Study:

    • To evaluate the efficacy and safety of subcutaneously implanted, fixed-rate artificial cardiac pacemakers in patients with complete heart block and Stokes-Adams disease.

    Main Methods:

    • Nine patients with complete heart block and Stokes-Adams disease, refractory to medical treatment, underwent implantation of fixed-rate artificial cardiac pacemakers.
    • Pacemaker function and patient outcomes, including seizure frequency and physical activity, were monitored.

    Main Results:

    • Eight out of nine patients showed adequate stimulation and significant improvement in physical activity.
    • Patients were free from seizures post-implantation, with a fixed rate of 60-65 beats per minute proving adequate.
    • One patient experienced a fatal outcome due to uremia one month post-operation.

    Conclusions:

    • Subcutaneously implanted artificial cardiac pacemakers offer a satisfactory treatment for selected patients with complete heart block and Stokes-Adams disease.
    • The potential for mechanical failure necessitates limiting pacemaker use to incapacitated patients unresponsive to medical management.

    Keywords:
    ADAMS-STOKES SYNDROMECEREBRAL ISCHEMIA, TRANSIENTCONVULSIONSGERIATRICSHEART ARRESTHEART BLOCKPACEMAKER, ARTIFICIALPHARMACOLOGYPOSTOPERATIVE COMPLICATIONSSURGERY, OPERATIVE

    More Related Videos

    Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection08:52

    Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection

    Published on: February 17, 2015

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine10:08

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

    Published on: February 17, 2018

    Related Concept Videos

    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Dysrhythmias VI: Management of Dysrhythmias01:25

    Dysrhythmias VI: Management of Dysrhythmias

    Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
    Conduction System of the Heart01:19

    Conduction System of the Heart

    Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
    The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...